RA Capital Management’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.28M | Buy |
6,681,307
+536,426
| +9% | +$585K | 0.12% | 51 |
|
|
2025
Q1 | $5.97M | Hold |
6,144,881
| – | – | 0.1% | 75 |
|
|
2024
Q4 | $9.09M | Hold |
6,144,881
| – | – | 0.12% | 74 |
|
|
2024
Q3 | $13M | Hold |
6,144,881
| – | – | 0.15% | 63 |
|
|
2024
Q2 | $15M | Hold |
6,144,881
| – | – | 0.2% | 56 |
|
|
2024
Q1 | $39.8M | Hold |
6,144,881
| – | – | 0.51% | 46 |
|
|
2023
Q4 | $23.7M | Hold |
6,144,881
| – | – | 0.37% | 43 |
|
|
2023
Q3 | $13.2M | Hold |
6,144,881
| – | – | 0.26% | 51 |
|
|
2023
Q2 | $18.7M | Hold |
6,144,881
| – | – | 0.35% | 44 |
|
|
2023
Q1 | $16M | Buy |
6,144,881
+1,853,000
| +43% | +$4.82M | 0.36% | 50 |
|
|
2022
Q4 | $8.8M | Hold |
4,291,881
| – | – | 0.18% | 53 |
|
|
2022
Q3 | $19.4M | Hold |
4,291,881
| – | – | 0.41% | 51 |
|
|
2022
Q2 | $17.6M | Hold |
4,291,881
| – | – | 0.47% | 51 |
|
|
2022
Q1 | $18.9M | Hold |
4,291,881
| – | – | 0.41% | 54 |
|
|
2021
Q4 | $51.1M | Hold |
4,291,881
| – | – | 0.9% | 31 |
|
|
2021
Q3 | $73.6M | Hold |
4,291,881
| – | – | 1.02% | 29 |
|
|
2021
Q2 | $74.9M | Buy |
+4,291,881
| New | +$74.9M | 1.2% | 25 |
|